The downgrade from Wolfe Research is likely to have a negative impact on CQP's stock price in the short term. The new rating of Underperform suggests that the analyst believes the stock will underperform its peers, which could lead to selling pressure and a decline in the stock price. The $43 price target also indicates a potential downside from the current stock price.